Real Experts. Real Trades. Real Profits
Hold onto your hats, folks, because Bone Biologics Corporation (NASDAQ: BBLG) is lighting up the premarket, soaring 80.5% as of this writing! This small-cap biotech is stealing the show, and the catalyst? A fresh patent application for their cutting-edge NELL-1...
Buckle up, folks, because EVgo Inc. (EVGO) is charging ahead like a Tesla on Ludicrous Mode! As of this writing, EVGO is up a jaw-dropping 38.26% today, May 6, 2025, making it one of the market’s biggest gainers. Why the electric buzz? The company just dropped its...
Bam! The market’s buzzing today, and FARO Technologies (NASDAQ: FARO) is stealing the spotlight with a jaw-dropping 33.78% gain as of this writing. Why the fireworks? AMETEK, a heavy hitter in industrial tools, just dropped a bombshell, announcing it’s scooping up...
Sorry everyone, it’s the end of the road. Take these last seconds to secure this Weekly Wiretaps deal; otherwise, consider us enemies. Just kidding! But I am disappointed… When you joined my email list, I thought you were invested in your success… That you...
Come on guys and gals! How could you miss the LAUNCH of my NEW Weekly Wiretaps service? You’re about to miss my #1 trade of the week, TODAY! Oh I know, it’s not easy to accept, but you really need to act quick, or you are GOING to miss this. I’m not...
Hey, listen up—because if you’re not paying attention to what’s happening in biotech right now, you’re missing out on the kind of fireworks that can turn a sleepy stock into a market mover overnight. Phio Pharmaceuticals (NASDAQ: PHIO), this gutsy...
AlphaTON Capital Corp. (ATON) analysis: TON ecosystem integration drives 50%+ revenue growth via decentralized AI infrastructure like Cocoon, with valuation and historical analogues.
ProPetro Holding Corp. (PUMP) investment analysis: Electrification via FORCE fleets and PROPWR positions PUMP for strong FCF growth and margin expansion in the Permian, with DCF valuation and historical analogues.
Nokia (NOK) stands at the forefront of 6G and AI-driven telecom innovation, with recent Nvidia investment and standardization partnerships signaling margin expansion. Explore the forward-looking thesis, valuation, risks, and sector context in this in-depth analysis for sophisticated investors.
Explore our in-depth analysis of Arcutis Biotherapeutics (ARQT), focusing on ZORYVE’s potential to disrupt the topical corticosteroid market and drive multi-year revenue growth in immuno-dermatology.